NCT02255617View on ClinicalTrials.gov

Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 23, 2014

Primary Completion Date

July 25, 2019

Study Completion Date

September 23, 2019

Conditions
Hepatic Encephalopathy
Interventions
BIOLOGICAL

Fecal Microbiota Transplant

Fecal transplant processed from routinely screened universal donors

Trial Locations (1)

Unknown

University of Alberta Hospital, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT02255617 - Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study | Biotech Hunter | Biotech Hunter